The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Contrast‐enhanced MRI for breast cancer screening
Open accessAbstract
Multiple studies in the first decade of the 21 st century have established contrast‐enhanced breast MRI as a screening modality for women with a hereditary or familial increased risk for the development of breast cancer. In recent studies, in women with various risk profiles, the sensitivity ranges between 81% and 100%, which is approximately twice as high as the sensitivity of mammography. The specificity increases in follow‐up rounds to around 97%, with positive predictive values for biopsy in the same range as for mammography. MRI preferentially detects the more aggressive/invasive types of breast cancer, but has a higher sensitivity than mammography for any type of cancer. This performance implies that in women screened with breast MRI, all other examinations must be regarded as supplemental. Mammography may yield ~5% additional cancers, mostly ductal carcinoma in situ, while slightly decreasing specificity and increasing the costs. Ultrasound has no supplemental value when MRI is used. Evidence is mounting that in other groups of women the performance of MRI is likewise superior to more conventional screening techniques. Particularly in women with a personal history of breast cancer, the gain seems to be high, but also in women with a biopsy history of lobular carcinoma in situ and even women at average risk, similar results are reported. Initial outcome studies show that breast MRI detects cancer earlier, which induces a stage‐shift increasing the survival benefit of screening. Cost‐effectiveness is still an issue, particularly for women at lower risk. Since costs of the MRI scan itself are a driving factor, efforts to reduce these costs are essential. The use of abbreviated MRI protocols may enable more widespread use of breast MRI for screening. Level of Evidence: 1 Technical Efficacy: Stage 5 J. Magn. Reson. Imaging 2019;50:377–390.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Kriege, M., Brekelmans, C. T. M., Boetes, C., Besnard, P. E., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Peterse, H., Tilanus-Linthorst, M. M. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031759 · Cited by 1,687
The benefits and harms of breast cancer screening: an independent review
(2012) · The Lancet · doi:10.1016/s0140-6736(12)61611-0 · Cited by 1,492
Kuhl, C. K., Schrading, S., Leutner, C. C., Morakkabati-Spitz, N., Wardelmann, E., Fimmers, R., Kuhn, W., & Schild, H. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.4960 · Cited by 1,147
Self-citationBreast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400382 · Cited by 851
Breast MRI: guidelines from the European Society of Breast Imaging
Mann, R. M., Kuhl, C. K., Kinkel, K., & Boetes, C. (2008) · European Radiology · doi:10.1007/s00330-008-0863-7 · Cited by 839
Self-citationMRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study
Kuhl, C. K., Schrading, S., Bieling, H. B., Wardelmann, E., Leutner, C. C., Koenig, R., Kuhn, W., & Schild, H. H. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61232-x · Cited by 711
Self-citationBreast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
Welch, H. G., Prorok, P. C., O’Malley, A. J., & Kramer, B. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600249 · Cited by 699
Kuhl, C. K., Schrading, S., Strobel, K., Schild, H. H., Hilgers, R.-D., & Bieling, H. B. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.5386 · Cited by 679
Self-citationOhuchi, N., Suzuki, A., Sobue, T., Kawai, M., Yamamoto, S., Zheng, Y.-F., Shiono, Y. N., Saito, H., Kuriyama, S., Tohno, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00774-6 · Cited by 616
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Couch, F. J., Shimelis, H., Hu, C., Hart, S. N., Polley, E. C., Na, J., Hallberg, E., Moore, R., Thomas, A., Lilyquist, J., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0424 · Cited by 611
Systematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
Kuhl, C. K., Schmutzler, R. K., Leutner, C. C., Kempe, A., Wardelmann, E., Hocke, A., Maringa, M., Pfeifer, U., Krebs, D., & Schild, H. H. (2000) · Radiology · doi:10.1148/radiology.215.1.r00ap01267 · Cited by 538
Self-citationKuhl, C., Weigel, S., Schrading, S., Arand, B., Bieling, H., König, R., Tombach, B., Leutner, C., Rieber-Brambs, A., Nordhoff, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0839 · Cited by 501
Self-citationSarica, O., Ozturk, E., Demirkurek, H. C., & Uluc, F. (2013) · Breast Care · doi:10.1159/000355833 · Cited by 356
Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer
Kuhl, C. K., Strobel, K., Bieling, H., Leutner, C., Schild, H. H., & Schrading, S. (2017) · Radiology · doi:10.1148/radiol.2016161444 · Cited by 350
Self-citationSardanelli, F., Podo, F., Santoro, F., Manoukian, S., Bergonzi, S., Trecate, G., Vergnaghi, D., Federico, M., Cortesi, L., Corcione, S., et al. (2011) · Investigative Radiology · doi:10.1097/rli.0b013e3181f3fcdf · Cited by 337
Riedl, C. C., Luft, N., Bernhart, C., Weber, M., Bernathova, M., Tea, M.-K. M., Rudas, M., Singer, C. F., & Helbich, T. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.8626 · Cited by 300
Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Stoutjesdijk, M. J., Boetes, C., Jager, G. J., Beex, L., Bult, P., Hendriks, J. H. C. L., Laheij, R. J. F., Massuger, L., van Die, L. E., Wobbes, T., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1095 · Cited by 289
Re: Magnetic Resonance Imaging and Mammography in Women With a Hereditary Risk of Breast Cancer
Goffin, J., Chappuis, P. O., Wong, N., & Foulkes, W. D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1754 · Cited by 284
Warner, E., Hill, K., Causer, P., Plewes, D., Jong, R., Yaffe, M., Foulkes, W. D., Ghadirian, P., Lynch, H., Couch, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0835 · Cited by 280
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
Plevritis, S. K., Kurian, A. W., Sigal, B. M., Daniel, B. L., Ikeda, D. M., Stockdale, F. E., & Garber, A. M. (2006) · JAMA · doi:10.1001/jama.295.20.2374 · Cited by 260
Tabár, L., Dean, P. B., Chen, T. H., Yen, A. M., Chen, S. L., Fann, J. C., Chiu, S. Y., Ku, M. M., Wu, W. Y., Hsu, C., et al. (2019) · Cancer · doi:10.1002/cncr.31840 · Cited by 246
Mann, R. M., Mus, R. D., van Zelst, J., Geppert, C., Karssemeijer, N., & Platel, B. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000057 · Cited by 226
Self-citationKing, T. A., Pilewskie, M., Muhsen, S., Patil, S., Mautner, S. K., Park, A., Oskar, S., Guerini-Rocco, E., Boafo, C., Gooch, J. C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4743 · Cited by 208
Bogner, W., Pinker-Domenig, K., Bickel, H., Chmelik, M., Weber, M., Helbich, T. H., Trattnig, S., & Gruber, S. (2012) · Radiology · doi:10.1148/radiol.12111494 · Cited by 204
Brandt, K. R., Scott, C. G., Ma, L., Mahmoudzadeh, A. P., Jensen, M. R., Whaley, D. H., Wu, F. F., Malkov, S., Hruska, C. B., Norman, A. D., et al. (2016) · Radiology · doi:10.1148/radiol.2015151261 · Cited by 183
Hagen, A. I., Kvistad, K. A., Maehle, L., Holmen, M. M., Aase, H., Styr, B., Vabø, A., Apold, J., Skaane, P., & Møller, P. (2007) · The Breast · doi:10.1016/j.breast.2007.01.006 · Cited by 175
Pinker, K., Moy, L., Sutton, E. J., Mann, R. M., Weber, M., Thakur, S. B., Jochelson, M. S., Bago-Horvath, Z., Morris, E. A., Baltzer, P. A., et al. (2018) · Investigative Radiology · doi:10.1097/rli.0000000000000465 · Cited by 163
Self-citationCho, N., Han, W., Han, B.-K., Bae, M. S., Ko, E. S., Nam, S. J., Chae, E. Y., Lee, J. W., Kim, S. H., Kang, B. J., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1256 · Cited by 158
MRI breast screening in high-risk women: cancer detection and survival analysis
MARIBS Group, Evans, D. G., Kesavan, N., Lim, Y. Y., Gadde, S., Hurley, E., Massat, N. J., Maxwell, A., Ingham, S. L., Eeles, R. A., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2931-9 · Cited by 156
Patterns of Breast Magnetic Resonance Imaging Use in Community Practice
Wernli, K. J., DeMartini, W. B., Ichikawa, L., Lehman, C. D., Onega, T., Kerlikowske, K. M., Henderson, L. M., Geller, B. M., Hofmann, M., & Yankaskas, B. C. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11963 · Cited by 148
Screening MRI in Women With a Personal History of Breast Cancer
Lehman, C. D., Lee, J. M., DeMartini, W. B., Hippe, D. S., Rendi, M. H., Kalish, G., Porter, P. L., Gralow, J. R., & Partridge, S. C. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv349 · Cited by 145
Baltzer, P., Benndorf, M., Dietzel, M., Gajda, M. R., Camara, O., & Kaiser, W. A. (2009) · European Radiology · doi:10.1007/s00330-009-1654-5 · Cited by 140
Chiarelli, A. M., Prummel, M. V., Muradali, D., Majpruz, V., Horgan, M., Carroll, J. C., Eisen, A. F., Meschino, W. S., Shumak, R. S., Warner, E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.8331 · Cited by 130
for the UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group, Griebsch, I., Brown, J., Boggis, C. R. M., Dixon, A. K., Dixon, M., Easton, D. F., Eeles, R. A., Evans, D. G., Gilbert, F. J., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603356 · Cited by 128
Rapid Increase in Breast Magnetic Resonance Imaging Use: Trends From 2000 to 2011
Stout, N. K., Nekhlyudov, L., Li, L., Malin, E. S., Ross‐Degnan, D., Buist, D. S. M., Rosenberg, M. A., Alfisher, M. M., & Fletcher, S. W. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.11958 · Cited by 123
Results of MRI Screening for Breast Cancer in High-Risk Patients with LCIS and Atypical Hyperplasia
Port, E. R., Park, A., Borgen, P. I., Morris, E. A., & Montgomery, L. L. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9195-5 · Cited by 120
Robertson, C., Ragupathy, S. A., Boachie, C., Dixon, J. M., Fraser, C., Hernández, R. A., Heys, S. D., Jack, W., Kerr, G., Lawrence, G., et al. (2011) · Health Technology Assessment · doi:10.3310/hta15340 · Cited by 116
Phi, X.-A., Saadatmand, S., de Bock, G. H., Warner, E., Sardanelli, F., Leach, M. O., Riedl, C. C., Trop, I., Hooning, M. J., Mandel, R., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.32 · Cited by 116
Moore, S. G., Shenoy, P. J., Fanucchi, L. C., Tumeh, J. W., & Flowers, C. R. (2009) · BMC Health Services Research · doi:10.1186/1472-6963-9-9 · Cited by 113
Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers
Krammer, J., Pinker, K., Robson, M. E., Gönen, M., Bernard‐Davila, B., Morris, E. A., Mangino, D. A., & Jochelson, M. S. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4198-4 · Cited by 113
Emaus, M. J., Bakker, M. F., Peeters, P. H. M., Loo, C. E., Mann, R. M., de Jong, M. D. F., Bisschops, R. H. C., Veltman, J., Duvivier, K. M., Lobbes, M. B. I., et al. (2015) · Radiology · doi:10.1148/radiol.2015141827 · Cited by 108
Self-citationSurvival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)
Saadatmand, S., Obdeijn, I., Rutgers, E. J., Oosterwijk, J. C., Tollenaar, R. A., Woldringh, G. H., Bergers, E., Verhoef, C., Heijnsdijk, E. A., Hooning, M. J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29534 · Cited by 96
Cost Effectiveness of Breast Cancer Screening With Contrast-Enhanced MRI in High-Risk Women
Taneja, C., Edelsberg, J., Weycker, D. A., Guo, A. X., Oster, G., & Weinreb, J. C. (2009) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2008.10.003 · Cited by 96
Screening Breast MR Imaging in Women with a History of Lobular Carcinoma in Situ
Sung, J. S., Malak, S. F., Bajaj, P., Alis, R., Dershaw, D. D., & Morris, E. A. (2011) · Radiology · doi:10.1148/radiol.11110091 · Cited by 96
Trimboli, R. M., Verardi, N., Cartia, F., Carbonaro, L. A., & Sardanelli, F. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11816 · Cited by 95
Schacht, D. V., Yamaguchi, K., Lai, J., et al. (2014) · American Journal of Roentgenology · doi:10.2214/ajr.13.11553 · Cited by 94
Breast MR Imaging Screening in Women with a History of Breast Conservation Therapy
Gweon, H. M., Cho, N., Han, W., Yi, A., Moon, H., Noh, D., & Moon, W. K. (2014) · Radiology · doi:10.1148/radiol.14131893 · Cited by 92
Earlier detection of breast cancer by surveillance of women at familial risk.
Tilanus-Linthorst, M., Bartels, C., Obdeijn, A. I. M., & Oudkerk, M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00337-8 · Cited by 91
Heijnsdijk, E. A. M., Warner, E., Gilbert, F. J., Tilanus‐Linthorst, M. M. A., Evans, D. G., Causer, P. A., Eeles, R. A., Kaas, R., Draisma, G., Ramsay, E. A., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1196 · Cited by 89
van Zelst, J. C. M., Vreemann, S., Witt, H.-J., Gubern‐Mérida, A., Dorrius, M. D., Duvivier, K. M., Lardenoije, S., Lobbes, M. B. I., Loo, C. E., Veldhuis, W. B., et al. (2018) · Investigative Radiology · doi:10.1097/rli.0000000000000494 · Cited by 86
Self-citationFilli, L., Ghafoor, S., Kenkel, D., Liu, W., Weiland, E., Andreisek, G., Frauenfelder, T., Runge, V. M., & Boss, A. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.10.009 · Cited by 84
Should we screen BRCA1 mutation carriers only with MRI? A multicenter study
Obdeijn, I.-M., Winter-Warnars, G. A. O., Mann, R. M., Hooning, M. J., Hunink, M. G. M., & Tilanus‐Linthorst, M. M. A. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2888-8 · Cited by 80
Self-citationImaging Surveillance After Primary Breast Cancer Treatment
Lam, D. L., Houssami, N., & Lee, J. M. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.16.16300 · Cited by 80
Gilbert, F. J., Warren, R. M. L., Kwan-Lim, G. E., Thompson, D. J., Eeles, R. A., Evans, D. G., Leach, M. O., & For the United Kingdom Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group (2009) · Radiology · doi:10.1148/radiol.2522081032 · Cited by 75
Vreemann, S., Gubern‐Mérida, A., Schlooz-Vries, M. S., Bult, P., van Gils, C. H., Hoogerbrugge, N., Karssemeijer, N., & Mann, R. M. (2017) · Radiology · doi:10.1148/radiol.2017170458 · Cited by 72
Self-citationKerlikowske, K. M., Scott, C. G., Mahmoudzadeh, A. P., Ma, L., Winham, S. J., Jensen, M. R., Wu, F. F., Malkov, S., Pankratz, V. S., Cummings, S. R., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-3008 · Cited by 72
Lee, J. M., McMahon, P. M., Kong, C. Y., Kopans, D. B., Ryan, P. D., Ozanne, E. M., Halpern, E. F., & Gazelle, G. S. (2010) · Radiology · doi:10.1148/radiol.09091086 · Cited by 69
Saadatmand, S., Tilanus‐Linthorst, M. M. A., Rutgers, E. J. T., Hoogerbrugge, N., Oosterwijk, J. C., Tollenaar, R. A. �. �., Hooning, M. J., Loo, C. E., Obdeijn, I.-M., Heijnsdijk, E. A. M., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt203 · Cited by 65
Undiagnosed Breast Cancer at MR Imaging: Analysis of Causes
Pages, E. B., Millet, I., Hoa, D., Doyon, F. C., & Taourel, P. (2012) · Radiology · doi:10.1148/radiol.12111917 · Cited by 61
Miles, R. C., Wan, F., Onega, T., Lenderink-Carpenter, A., O’Meara, E. S., Zhu, W., Henderson, L. M., Haas, J. S., Hill, D. A., Tosteson, A. N. A., et al. (2018) · Journal of Women s Health · doi:10.1089/jwh.2017.6623 · Cited by 60
Møller, P., Stormorken, A. T., Jonsrud, C., Holmen, M. M., Hagen, A. I., Clark, N., Vabø, A., Sun, P., Narod, S. A., & Mæhle, L. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2540-z · Cited by 59
Breast magnetic resonance imaging (MRI) surveillance in breast cancer survivors
Weinstock, C., Campassi, C., Goloubeva, O. G., Wooten, K., Kesmodel, S. B., Bellevance, E., Feigenberg, S. J., Ioffe, O. B., & Tkaczuk, K. H. R. (2015) · SpringerPlus · doi:10.1186/s40064-015-1158-5 · Cited by 58
Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery
Choi, B. H., Choi, N., Kim, M. Y., Yang, J., Yoo, Y. B., & Jung, H. K. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4530-z · Cited by 57
Screening Breast MRI in Patients Previously Treated for Breast Cancer
Giess, C. S., Poole, P. S., Chikarmane, S. A., Sippo, D. A., & Birdwell, R. L. (2015) · Academic Radiology · doi:10.1016/j.acra.2015.05.009 · Cited by 56
Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers
Pataky, R. E., Armstrong, L., Chia, S., Coldman, A. J., Kim‐Sing, C., McGillivray, B. C., Scott, J., Wilson, C., & Peacock, S. J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-339 · Cited by 54
Houssami, N., Given-Wilson, R., & Ciatto, S. (2009) · Journal of Medical Imaging and Radiation Oncology · doi:10.1111/j.1754-9485.2009.02062.x · Cited by 52
Improvement in DCIS Detection Rates by MRI Over Time in a High-Risk Breast Screening Study
Warner, E., Causer, P. A., Wong, J. W., Wright, F. C., Jong, R. A., Hill, K. A., Messner, S. J., Yaffe, M. J., Narod, S. A., & Plewes, D. B. (2011) · The Breast Journal · doi:10.1111/j.1524-4741.2010.01018.x · Cited by 50
Vreemann, S., van Zelst, J. C. M., Schlooz-Vries, M. S., Bult, P., Hoogerbrugge, N., Karssemeijer, N., Gubern‐Mérida, A., & Mann, R. M. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1019-6 · Cited by 49
Self-citationBreast Cancer Screening and Diagnosis
Gegios, A. R., Peterson, M. S., & Fowler, A. M. (2023) · PET Clinics · doi:10.1016/j.cpet.2023.04.003 · Cited by 46
Kriege, M., Brekelmans, C. T. M., Peterse, H. L., Obdeijn, I. M., Boetes, C., Zonderland, H. M., Muller, S. H., Kok, T., Manoliu, R. A., Besnard, A. P. E., et al. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9341-6 · Cited by 45
Five-Year Risk for Interval-Invasive Second Breast Cancer
Lee, J. M., Buist, D. S. M., Houssami, N., Dowling, E. C., Halpern, E. F., Gazelle, G. S., Lehman, C. D., Henderson, L. M., & Hubbard, R. A. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv109 · Cited by 40
Podo, F., Santoro, F., Leo, G. D., Manoukian, S., de Giacomi, C., Corcione, S., Cortesi, L., Carbonaro, L. A., Trimboli, R. M., Cilotti, A., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0459 · Cited by 38
The frequency of missed breast cancers in women participating in a high-risk MRI screening program
Vreemann, S., Gubern-Merida, A., Lardenoije, S., Bult, P., Karssemeijer, N., Pinker, K., & Mann, R. M. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4688-z · Cited by 37
Self-citationYamaguchi, K., Schacht, D. V., Newstead, G. M., Bradbury, A. R., Verp, M. S., Olopade, O. I., & Abé, H. (2013) · American Journal of Roentgenology · doi:10.2214/ajr.12.9707 · Cited by 36
Rosenthal, E. T., Evans, B. A., Kidd, J., Brown, K. L., Gorringe, H., van Orman, M., & Manley, S. (2016) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2016.10.003 · Cited by 30
Chereau, E., Uzan, C., Balleyguier, C., Chevalier, J., Paillerets, B. B., Caron, O., Rimareix, F., Mathieu, M., Koskas, M., Bourgier, C., et al. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.022 · Cited by 28
Adank, M. A., Verhoef, S., Oldenburg, R. A., Schmidt, M. K., Hooning, M. J., Martens, J. W. M., Broeks, A., Rookus, M. A., Waisfisz, Q., Lissenberg-Witte, B. I., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.01.009 · Cited by 26
Obdeijn, I.-M., Heijnsdijk, E. A. M., Hunink, M. G. M., Tilanus‐Linthorst, M. M. A., & de Koning, H. J. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.05.012 · Cited by 20
van Marcke, C., Vikkula, M., & Duhoux, F. P. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.01.017 · Cited by 18
Cited by
Current State of Breast Cancer Diagnosis, Treatment, and Theranostics
Bhushan, A., Gonsalves, A., & Menon, J. U. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050723 · Cited by 298
Sessa, C., Balmaña, J., Bober, S. L., Cardoso, M. J., Colombo, N., Curigliano, G., Domchek, S. M., Evans, D. G., Fischerova, D., Harbeck, N., et al. (2023) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.004 · Cited by 295
Self-citation
Metadata
- Authors
- Mann, R. M., Kuhl, C. K., & Moy, L.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2019-01-18
- Volume
- 50
- Issue
- 2
- Pages
- 377-390
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2910570496
- Cited by
- 356
- References
- 85
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.